nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—TACR3—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0949	0.0949	CbGpPWpGaD
Aprepitant—TACR3—Peptide GPCRs—TSHR—adrenal gland cancer	0.0507	0.0507	CbGpPWpGaD
Aprepitant—TACR1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.0463	0.0463	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0452	0.0452	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0404	0.0404	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0299	0.0299	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0271	0.0271	CbGpPWpGaD
Aprepitant—TACR1—Peptide GPCRs—TSHR—adrenal gland cancer	0.0247	0.0247	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0242	0.0242	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0228	0.0228	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0221	0.0221	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.0197	0.0197	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0179	0.0179	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.016	0.016	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0146	0.0146	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0137	0.0137	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.0132	0.0132	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0129	0.0129	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—TSHR—adrenal gland cancer	0.0122	0.0122	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.0118	0.0118	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0117	0.0117	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0111	0.0111	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—CDC42—adrenal gland cancer	0.0104	0.0104	CbGpPWpGaD
Aprepitant—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0101	0.0101	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00978	0.00978	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00933	0.00933	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00876	0.00876	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0078	0.0078	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00772	0.00772	CbGpPWpGaD
Aprepitant—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00717	0.00717	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00708	0.00708	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00701	0.00701	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00691	0.00691	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00688	0.00688	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00667	0.00667	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—RB1—adrenal gland cancer	0.00647	0.00647	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00642	0.00642	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00629	0.00629	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00626	0.00626	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00625	0.00625	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00604	0.00604	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00594	0.00594	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00571	0.00571	CbGpPWpGaD
Aprepitant—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00554	0.00554	CbGpPWpGaD
Aprepitant—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00553	0.00553	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.00532	0.00532	CbGpPWpGaD
Aprepitant—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00505	0.00505	CbGpPWpGaD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00481	0.00481	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00478	0.00478	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—POMC—adrenal gland cancer	0.00477	0.00477	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.00456	0.00456	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00448	0.00448	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00419	0.00419	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00414	0.00414	CbGpPWpGaD
Aprepitant—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00411	0.00411	CbGpPWpGaD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00411	0.00411	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.004	0.004	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00381	0.00381	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CDC42—adrenal gland cancer	0.0038	0.0038	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—SPRY2—adrenal gland cancer	0.00379	0.00379	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00377	0.00377	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00377	0.00377	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TSHR—adrenal gland cancer	0.00369	0.00369	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—GNAS—adrenal gland cancer	0.00363	0.00363	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MEN1—adrenal gland cancer	0.00347	0.00347	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00346	0.00346	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00342	0.00342	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00337	0.00337	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00336	0.00336	CbGpPWpGaD
Aprepitant—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00334	0.00334	CbGpPWpGaD
Aprepitant—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00333	0.00333	CbGpPWpGaD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TP53—adrenal gland cancer	0.00317	0.00317	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00314	0.00314	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00306	0.00306	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00305	0.00305	CbGpPWpGaD
Aprepitant—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00297	0.00297	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00295	0.00295	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—POMC—adrenal gland cancer	0.00269	0.00269	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00265	0.00265	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—POMC—adrenal gland cancer	0.00245	0.00245	CbGpPWpGaD
Aprepitant—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00241	0.00241	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—POMC—adrenal gland cancer	0.00233	0.00233	CbGpPWpGaD
Aprepitant—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0023	0.0023	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CDC42—adrenal gland cancer	0.00225	0.00225	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00219	0.00219	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IGF2—adrenal gland cancer	0.00216	0.00216	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00215	0.00215	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—GNAS—adrenal gland cancer	0.00215	0.00215	CbGpPWpGaD
Aprepitant—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Aprepitant—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0021	0.0021	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IGF1R—adrenal gland cancer	0.00209	0.00209	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00204	0.00204	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00202	0.00202	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00195	0.00195	CbGpPWpGaD
Aprepitant—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Aprepitant—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CDC42—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00185	0.00185	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TERT—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TSHR—adrenal gland cancer	0.0018	0.0018	CbGpPWpGaD
Aprepitant—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00179	0.00179	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—GNAS—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Aprepitant—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00177	0.00177	CbGpPWpGaD
Aprepitant—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MEN1—adrenal gland cancer	0.00169	0.00169	CbGpPWpGaD
Aprepitant—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—BAD—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Aprepitant—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—POMC—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—BRAF—adrenal gland cancer	0.00143	0.00143	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—EGFR—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Aprepitant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00138	0.00138	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—POMC—adrenal gland cancer	0.00132	0.00132	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PRKACA—adrenal gland cancer	0.00129	0.00129	CbGpPWpGaD
Aprepitant—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—POMC—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.00115	0.00115	CbGpPWpGaD
Aprepitant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CDC42—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF2—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—GNAS—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IGF1R—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.00102	0.00102	CbGpPWpGaD
Aprepitant—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.00099	0.00099	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000955	0.000955	CbGpPWpGaD
Aprepitant—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000903	0.000903	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000885	0.000885	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TERT—adrenal gland cancer	0.00088	0.00088	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000871	0.000871	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—EGFR—adrenal gland cancer	0.000817	0.000817	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000807	0.000807	CbGpPWpGaD
Aprepitant—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000771	0.000771	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BAD—adrenal gland cancer	0.000765	0.000765	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.000761	0.000761	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000744	0.000744	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000738	0.000738	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000738	0.000738	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—POMC—adrenal gland cancer	0.000706	0.000706	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—BRAF—adrenal gland cancer	0.000697	0.000697	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000697	0.000697	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.00069	0.00069	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TP53—adrenal gland cancer	0.000686	0.000686	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000675	0.000675	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000635	0.000635	CbGpPWpGaD
Aprepitant—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000595	0.000595	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.00057	0.00057	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.00057	0.00057	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.000555	0.000555	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.00055	0.00055	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000543	0.000543	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000532	0.000532	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.00052	0.00052	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.00052	0.00052	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000504	0.000504	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.00045	0.00045	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000444	0.000444	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000444	0.000444	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000442	0.000442	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000425	0.000425	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000401	0.000401	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—EGFR—adrenal gland cancer	0.000399	0.000399	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000388	0.000388	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00038	0.00038	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000347	0.000347	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000343	0.000343	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000343	0.000343	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TP53—adrenal gland cancer	0.000335	0.000335	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000331	0.000331	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.000325	0.000325	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000319	0.000319	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.00031	0.00031	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000303	0.000303	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—adrenal gland cancer	0.000303	0.000303	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000296	0.000296	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000283	0.000283	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000277	0.000277	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000256	0.000256	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000251	0.000251	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000247	0.000247	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000242	0.000242	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	0.000242	0.000242	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000236	0.000236	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000229	0.000229	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000225	0.000225	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000219	0.000219	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.000196	0.000196	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000192	0.000192	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000187	0.000187	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	0.000175	0.000175	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000169	0.000169	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000154	0.000154	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000151	0.000151	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000148	0.000148	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000135	0.000135	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—adrenal gland cancer	0.000132	0.000132	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000123	0.000123	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	0.000105	0.000105	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000102	0.000102	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.12e-05	8.12e-05	CbGpPWpGaD
